Perspective Therapeutics (CATX) Current Assets (2011 - 2026)

Perspective Therapeutics (CATX) has 16 years of Current Assets data on file, last reported at $275.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 27.63% year-over-year to $275.4 million; the trailing twelve-month figure through Mar 2026 stood at $275.4 million (up 27.63% YoY), and the FY2025 full-year result was $148.4 million, down 35.81% from the prior year.
• Current Assets advanced to $275.4 million in Q1 2026, from $148.4 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $294.2 million in Q2 2024 to a low of $16.8 million in Q4 2023.
• A 5-year average of $137.7 million and a median of $148.4 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets slumped 68.36% in 2023 and soared 1272.93% in 2024, its largest moves.
• Tracing CATX's Current Assets over 5 years: stood at $53.2 million in 2022, then tumbled by 68.36% to $16.8 million in 2023, then soared by 1272.93% to $231.2 million in 2024, then tumbled by 35.81% to $148.4 million in 2025, then soared by 85.56% to $275.4 million in 2026.
• Business Quant data shows CATX's Current Assets at $275.4 million in Q1 2026, $148.4 million in Q4 2025, and $178.5 million in Q3 2025.